Bevirimat

CAS No. 174022-42-5

Bevirimat( PA-457 | MPC-4326 | YK FH312 )

Catalog No. M20655 CAS No. 174022-42-5

Bevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 147 In Stock
25MG 327 In Stock
50MG 484 In Stock
100MG 691 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bevirimat
  • Note
    Research use only, not for human use.
  • Brief Description
    Bevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
  • Description
    Bevirimat(PA-457) is a first-in-class inhibitor of HIV-1 maturation blocking the cleavage of the Gag capsid (CA) precursor CA-SPI to mature CA protein during virion maturation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PA-457 | MPC-4326 | YK FH312
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV-1
  • Research Area
    Infection
  • Indication
    HIV-1 Infection

Chemical Information

  • CAS Number
    174022-42-5
  • Formula Weight
    584.83
  • Molecular Formula
    C36H56O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (85.49 mM)
  • SMILES
    [H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)C(O)=O)C(C)=C
  • Chemical Name
    (1R3aS5aR5bR7aR9S11aR11bR13aR13bR)-9-((3-carboxy-3-methylbutanoyl)oxy)-5a5b8811a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Smith P F Ogundele A Forrest A et al. Phase I and II Study of the Safety Virologic Effect and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3′3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection[J]. Antimicrobial Agents & Chemotherapy 2007 51(10):3574.
molnova catalog
related products
  • BI 224436

    BI 224436 is a potent, specific, noncatalytic site integrase inhibitor (NCINI) of HIV-1 with EC50 of 11-27 nM against different HIV-1 laboratory strains.

  • IMB-301

    IMB-301 (NSC 301209) is a small molecule inhibitor that target the binding interface of the HIV-1 Vif/hA3G complex.

  • Etravirine

    A second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) for treatment of HIV-1 infection.